Literature DB >> 10421884

In vitro study concerning the efficiency of the frequency-doubled double-pulse Neodymium:YAG laser (FREDDY) for lithotripsy of calculi in the urinary tract.

T Zörcher1, J Hochberger, K M Schrott, R Kühn, W Schafhauser.   

Abstract

BACKGROUND AND OBJECTIVES: In a preclinical study we have tested both in vitro and in vivo, a new type of pulsed solid-state laser system that has not been applied in urology so far and has been developed for optimized intracorporal lithotripsy of biliary, salivary, and urinary calculi. STUDY DESIGN/
MATERIALS AND METHODS: Sixty one calculi from the human urinary tract were split in vitro into fragments with a remaining particle size of </= 2 mm using the prototype of a short-pulsed passively Q-switched and frequency-doubled double-pulse Neodymium:YAG laser. In a supplementary animal test, the bladder mucosa of five rabbits was directly exposed to a highly rated laser beam to be able to assess the tissue lesion potential of the system.
RESULTS: All the 61 urinary calculi with different composition were successfully split in vitro within a short period of time (2.5 +/- 4.6 minutes). During histopathologic examination of the exposed bladder walls of the rabbits only a small tissue lesion potential with urothelium changes exclusively at the surface was ascertained.
CONCLUSION: The high degree of fragmentation efficiency, the purchase and maintenance costs, which due to its design are substantially lower in comparison to other laser lithotriptors, and the high degree of safety during application make this new laser a real alternative not only to the present laser lithotripsy systems but also to common ballistic lithotriptors. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421884     DOI: 10.1002/(sici)1096-9101(1999)25:1<38::aid-lsm5>3.0.co;2-l

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  10 in total

1.  Making medicines that children can take.

Authors:  A J Nunn
Journal:  Arch Dis Child       Date:  2003-05       Impact factor: 3.791

2.  [The frequency-doubled double-pulse Neodym:YAG laser lithotripter (FREDDY) in lithotripsy of urinary stones. First clinical experience].

Authors:  A Ebert; J Stangl; R Kühn; W Schafhauser
Journal:  Urologe A       Date:  2003-03-05       Impact factor: 0.639

3.  How Should Biliary Stones be Managed?

Authors:  Chan Sup Shim
Journal:  Gut Liver       Date:  2010-06-16       Impact factor: 4.519

Review 4.  The future of lasers in urology.

Authors:  Sean A Pierre; David M Albala
Journal:  World J Urol       Date:  2007-06-14       Impact factor: 4.226

5.  Clinical usefulness of transpapillary removal of common bile duct stones by frequency doubled double pulse Nd:YAG laser.

Authors:  Tae-Hyeon Kim; Hyo-Jeong Oh; Chang-Soo Choi; Dong-Han Yeom; Suck-Chei Choi
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

6.  Neodymium:Yttrium Aluminum Garnet laser for mini-percutaneous treatment of upper urinary tract stones.

Authors:  Hongbo Luo; Xiuheng Liu; Shengqi Lv
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-04

Review 7.  Lasers in clinical urology: state of the art and new horizons.

Authors:  Andrew J Marks; Joel M H Teichman
Journal:  World J Urol       Date:  2007-03-28       Impact factor: 3.661

8.  Laparoscopic Transcystic Treatment Biliary Calculi by Laser Lithotripsy.

Authors:  Jun Liu; Lan Jin; Zhongtao Zhang
Journal:  JSLS       Date:  2016 Oct-Dec       Impact factor: 2.172

Review 9.  Advances in Lasers for the Treatment of Stones-a Systematic Review.

Authors:  Peter Kronenberg; Bhaskar Somani
Journal:  Curr Urol Rep       Date:  2018-05-17       Impact factor: 3.092

10.  Holmium laser lithotripsy improves the rate of successful transcystic laparoscopic common bile duct exploration.

Authors:  Timothy Jones; Jasim Al Musawi; Lalin Navaratne; Alberto Martinez-Isla
Journal:  Langenbecks Arch Surg       Date:  2019-12-11       Impact factor: 3.445

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.